Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Brent A. Neuschwander‐Tetri(Saint Louis University), Stephen H. Caldwell(University of Virginia)
Cited by 2,149
Related Papers
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Liver biopsy†
|Hepatology|2008|1.9k
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis
|Hepatology|2010|1.1k
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
|New England Journal of Medicine|2021|1.1k